You are here: Industry Insights > Financial Report

News List

DIL reports a 115 per cent hike in PAT, releases financial report expressbpd
May 29, 2019
The company recently released a consolidated financial report for Q4FY19 and FY19, registered a 34 per cent hike in net revenue
Johnson & Johnson drops out of the race for Pfizer consumer unit, paving the way for GSK, Reckitt fiercepharma
January 26, 2018
Johnson & Johnson discloses 4Q financial status.
Transgene Announces Financial Calendar for 2018 biospace
December 26, 2017
TRANSGENE S.A. (Paris:TNG) today announced its financial reporting dates for 2018
Financial Report: Johnson & Johnson contractpharma
July 27, 2017
Worldwide Pharmaceutical sales were flat at $8.6 billion in the quarter. Domestic sales were down 3%; international sales increased 3%, which reflected an operational increase of 6% and a negative currency impact of 3%. Remicade sales were down 14% to $1.
Financial Report: AMRI contractpharma
May 11, 2017
Contract revenue for the quarter up 56%
Financial Report: Regeneron contractpharma
May 05, 2017
Global EYLEA sales were up 12% in the quarter to $1.3 billion. Sales of EYLEA in the U.S. increased 9% to $854 million.
Financial Report: Pfizer contractpharma
May 03, 2017
Innovative Health sales were $7.4 billion in the quarter, up 5% driven by key brands including Ibrance and Eliquis, the addition of Xtandi revenues in the U.S. resulting from the September 2016 acquisition of Medivation...
Financial Report: Merck contractpharma
May 03, 2017
Pharmaceutical sales were up 1% to $8.2 billion, driven by oncology, hepatitis C and vaccines, largely offset by the loss of market exclusivity for ZETIA, CUBICIN, and NASONEX。。。
Financial Report: Roche contractpharma
April 28, 2017
Pharmaceuticals sales up 3% in the quarter
Financial Report: Johnson & Johnson contractpharma
April 20, 2017
Domestic sales increased 0.6%. International sales increased 2.8%, reflecting operational growth of 3.6% and a negative currency impact of 0.8%.

Previous page 1 2 3 Next page